Han KH - Search Results

1

Positioning and indication of sorafenib in the treatment algorithm and real practice setting: Western and eastern approach--Asian perspective.

Lee JM, Han KH. Lee JM, et al. Among authors: han kh. Oncology. 2010 Jul;78 Suppl 1:167-71. doi: 10.1159/000315246. Epub 2010 Jul 8. Oncology. 2010. PMID: 20616600 Review.

2

Treatment of non-resectable hepatocellular carcinoma.

Han KH, Lee JT, Seong J. Han KH, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S424-7. doi: 10.1046/j.1440-1746.17.s3.39.x. J Gastroenterol Hepatol. 2002. PMID: 12472975 Review. No abstract available.

3

[Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry].

Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, Hong SP, Chung HJ, Kim SO, Han KH, Chon CY, Moon YM. Lee JM, et al. Among authors: han kh. Korean J Hepatol. 2004 Dec;10(4):260-70. Korean J Hepatol. 2004. PMID: 15613801 Korean.

4

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, Han KH, Park C, Moon YM, Chon CY. Ahn SH, et al. Among authors: han kh. J Hepatol. 2005 Feb;42(2):188-94. doi: 10.1016/j.jhep.2004.10.026. J Hepatol. 2005. PMID: 15664243

5

[Natural history of HBeAg negative chronic hepatitis B virus infection: a cohort study].

Moon CM, Kim DY, Song KJ, Kim JK, Lee HW, Lee JM, Yoon KT, Paik YH, Kim DK, Han KH, Chon CY, Moon YM, Ahn SH. Moon CM, et al. Among authors: han kh. Korean J Hepatol. 2006 Jun;12(2):163-72. Korean J Hepatol. 2006. PMID: 16804341 Korean.

6

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

Kim DY, Paik YH, Ahn SH, Youn YJ, Choi JW, Kim JK, Lee KS, Chon CY, Han KH. Kim DY, et al. Among authors: han kh. Oncology. 2007;72 Suppl 1:52-7. doi: 10.1159/000111707. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087182

7

Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.

Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH. Yoon KT, et al. Among authors: han kh. Oncology. 2007;72 Suppl 1:104-10. doi: 10.1159/000111715. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087190

8

Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.

Kim BK, Han KH, Park YN, Park MS, Kim KS, Choi JS, Moon BS, Chon CY, Moon YM, Ahn SH. Kim BK, et al. Among authors: han kh. J Surg Oncol. 2008 Mar 1;97(3):246-52. doi: 10.1002/jso.20953. J Surg Oncol. 2008. PMID: 18095300

9

Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors.

Kim SU, Kim DY, Park JY, Ahn SH, Nah HJ, Chon CY, Han KH. Kim SU, et al. Among authors: han kh. J Cancer Res Clin Oncol. 2008 Dec;134(12):1377-84. doi: 10.1007/s00432-008-0410-6. Epub 2008 May 16. J Cancer Res Clin Oncol. 2008. PMID: 18483745

10

Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.

Kim DY, Kim SU, Ahn SH, Park JY, Lee JM, Park YN, Yoon KT, Paik YH, Lee KS, Chon CY, Han KH. Kim DY, et al. Among authors: han kh. Dig Dis Sci. 2009 Aug;54(8):1758-63. doi: 10.1007/s10620-008-0541-2. Epub 2008 Nov 13. Dig Dis Sci. 2009. PMID: 19005758 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,602 results

Search Page

Filters